Erasca, Inc. Common Stock (ERAS) is a publicly traded Healthcare sector company. As of July 14, 2026, ERAS trades at $17.58 with a market cap of $5.76B and a P/E ratio of -40.58. ERAS moved -3.48% today. Year to date, ERAS is +405.65%; over the trailing twelve months it is +1134.48%. Its 52-week range spans $1.01 to $24.28. Analyst consensus is strong buy with an average price target of $22.25. Rallies surfaces ERAS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ERAS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $17.58 |
| Market Cap | $5.76B |
| P/E Ratio | -40.58 |
| EPS | $-0.44 |
| Dividend Yield | 0.00% |
| 52-Week High | $24.28 |
| 52-Week Low | $1.01 |
| Volume | 1.40M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-124.55M |
| Gross Margin | 0.00% |
8 analysts cover ERAS: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $22.25.